Efficacy and Pharmacokinetics Evaluation of a Single Oral Dose of Afoxolaner against Sarcoptesscabiei in the Porcine Scabies Model for Human Infestation

Author:

Bernigaud Charlotte12,Fang Fang13,Fischer Katja4,Lespine Anne5,Aho Ludwig S.6,Mullins Amanda J.7,Tecle Berhane8,Kelly Andrew9,Sutra Jean-François5,Moreau Francis10,Lilin Thomas10,Beugnet Frédéric11,Botterel Françoise112,Chosidow Olivier213,Guillot Jacques114

Affiliation:

1. Research Group Dynamyc, EA7380, Université Paris-Est Créteil, Créteil, France

2. Department of Dermatology, AP-HP, Hôpital Henri Mondor, Université Paris-Est, Créteil, France

3. Department of Parasitology, College of Animal Science and Technology, Guangxi University, Nanning, China

4. Scabies Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia

5. Toxalim, Research Centre in Food Toxicology, INRA, INP-ENVT, INP-EI-Purpan, Université de Toulouse, Toulouse, France

6. Epidemiology and Infection Control Unit, University Hospital of Dijon, Dijon, France

7. Missouri Research Center, Merial, Fulton, Missouri, USA

8. Pharmacokinetics and Drug Metabolism, Boehringer Ingelheim Animal Health, North Brunswick, New Jersey, USA

9. Department of Agriculture, Fisheries and Forestry, Queensland Animal Science Precinct, University of Queensland, Gatton, Australia

10. Centre de Recherche BioMédicale, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France

11. Merial, Lyon, France

12. AP-HP, Hôpital Henri Mondor, Parasitology and Mycology, Department of Microbiology, DHU VIC, Université Paris-Est, Créteil, France

13. EA 7379, EpiDermE, Epidémiologie en Dermatologie et Evaluation des Thérapeutiques and INSERM, CIC 1430, Créteil, France

14. Department of Parasitology, Biopôle Alfort, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France

Abstract

Scabies is a major and potentially growing public health problem worldwide with an unmet need for acaricidal agents with greater efficacy and improved pharmacological properties for its treatment. The objective of the present study was to assess the efficacy and describe the pharmacokinetics profile of a novel acaricide, afoxolaner (AFX), in a relevant experimental porcine model.

Funder

Socitété française de dermatologie

Fondation René Touraibe pour la Dermatologie

China Scholarship Council

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3